Читать книгу Demystifying Research for Medical and Healthcare Students - John L. Anderson - Страница 63

1 ABPI. (2014). Guidelines for phase 1 clinical trials: 2012 edition. (Updated in 2014 by Arnold & Porter LLP on behalf of the ABPI.)

2 Arkenau H‐T, Olmos D, Ang JE, et al. (2008). Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience. British Journal of Cancer 98, 1029–1033.

3 Attarwala H. (2010). TGN1412: from discovery to disaster. Journal of Young Pharmacists 2(3), 332–336.

4 Cancer Research UK. (2020). Phase 1 trial. Available at https://www.cancerresearchuk.org/about‐cancer/find‐a‐clinical‐trial/what‐clinical‐trials‐are/phases‐of‐clinical‐trials (accessed 6 May 2020).

5 Chen SC, Sinai N, Bedarida G, et al. (2017). Phase 1 healthy volunteer willingness to participate and enrollment preferences. Clinical Trials 14(5), 537–546.

6 Health Research Authority. (2020). Phase 1 clinical trials. Available at https://www.hra.nhs.uk/planning‐and‐improving‐research/policies‐standards‐legislation/phase‐1‐clinical‐trials (accessed 6 May 2020).

7 Kerbrat A, Ferre JC, Fillatre P, et al. (2016). Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase. The New England Journal of Medicine 375, 1717–1725.

8 Matt L and Carl E. (2018). Avoiding exploitation in phase I clinical trials: more than (un)just compensation. The Journal of Law, Medicine & Ethics 46, 52–63.

9 Suntharalingam G, Perry MR, Ward S, et al. (2006). Cytokine storm in a phase 1 trial of the anti‐CD28 monoclonal antibody TGN1412. The New England Journal of Medicine 355(10), 1018–1028.